A drug-free treatment for COVID-19
EmitBio fills a critical gap in available treatment options for COVID-19 and other respiratory diseases.
The RD-X19™ light therapy device is an at-home, antiviral treatment in development to speed up recovery, test negative faster, and reduce severity of disease symptoms.
Light-based
The RD-X19 is a drug-free alternative that delivers precise wavelengths of light.
Targeted
The precise light targets the oropharynx to disrupt infection at the source.
Antiviral
Eliminates invading pathogens and stimulates host defense to create an antiviral environment.
Redefining Respiratory Care
We believe there should be a safe, effective, drug-free option in the treatment of respiratory diseases.
EmitBio is committed to finding better treatments for patients and relieve the burden providers have carried in recent years.
Product Pipeline
COVID-19
Preclinical
Human Safety(Phase 1)
Feasibility(Phase 2)
Pivotal(Phase 3)
Commercialized
Mild COVID-19
Long COVID (PCC)
Other Respiratory
Preclinical
Human Safety(Phase 1)
Feasibility(Phase 2)
Pivotal(Phase 3)
Commercialized
RSV
Flu
Earn up to $1,080 in EmitBio’s Clinical Study.
Press Mentions
EmitBio to Present Research on Novel Light-Based Antiviral Therapy at the World Congress on Infectious Diseases (October 23-25, 2023)
News Article
COVID-19 treatment at home could come from Durham firm’s blue light tech
News Article
Researchers Suggest That Visible Blue Light Is a Safe and Variant-Agnostic Therapy against SARS-CoV-2
News Article
